España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Lineage Cell Therapeutics
LCTX
AMEX
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Lineage Cell Therapeutics (LCTX) Forecast
News
Earnings
Lineage Cell Therapeutics (LCTX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Lineage Cell Therapeutics (AMEX:LCTX) Stock
Lineage Cell Therapeutics Stock (AMEX: LCTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, January 10, 2025
Maxim Group Maintains Buy on Lineage Cell The...
Benzinga Newsdesk
Friday, January 03, 2025
The Analyst Verdict: Lineage Cell Therapeutics In The Eyes Of 4 Experts
Benzinga Insights
D. Boral Capital Maintains Buy on Lineage Cel...
Benzinga Newsdesk
Wednesday, December 04, 2024
HC Wainwright & Co. Maintains Buy on Lineage ...
Benzinga Newsdesk
Wednesday, November 20, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Lineage Cell Therapeutics shares are trading ...
Benzinga Newsdesk
D. Boral Capital Maintains Buy on Lineage Cel...
Benzinga Newsdesk
Lineage Cell Therapeutics Entered Into Defini...
Benzinga Newsdesk
Monday, November 18, 2024
D. Boral Capital Initiates Coverage On Lineag...
Benzinga Newsdesk
Thursday, November 14, 2024
Lineage Cell Therapeutics Q3 2024 GAAP EPS $(...
Benzinga Newsdesk
Earnings Scheduled For November 14, 2024
Benzinga Insights
Wednesday, November 13, 2024
Lineage Cell Therapeutics's Earnings Outlook
Benzinga Insights
Wednesday, September 18, 2024
Lineage Presents Preclinical Data On Its Audi...
Benzinga Newsdesk
Tuesday, August 20, 2024
Craig-Hallum Initiates Coverage On Lineage Ce...
Benzinga Newsdesk
Thursday, August 08, 2024
Lineage Cell Therapeutics shares are trading ...
Benzinga Newsdesk
Lineage Cell Therapeutics Q2 EPS $(0.03) Beat...
Benzinga Newsdesk
Tuesday, July 02, 2024
Lineage Cell Therapeutics Added 2024 Russell ...
Benzinga Newsdesk
Thursday, May 09, 2024
Lineage Cell Therapeutics Q1 2024 GAAP EPS $(...
Benzinga Newsdesk
Monday, May 06, 2024
Lineage Cell Therapeutics shares are trading ...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Lineage...
Benzinga Newsdesk
Lineage Cell Therapeutics Announces OpRegen P...
Benzinga Newsdesk
Friday, March 22, 2024
Lineage Cell Therapeutics Inc May Offer And S...
Benzinga Newsdesk
Lineage Cell Therapeutics Entered Into Sales ...
Benzinga Newsdesk
Wednesday, March 13, 2024
Lineage Cell Therapeutics, Inc. Announces RG6501 (OpRegen) Phase 1/2a Clinical Study 24 Month Results To Be Featured At 2024 Retinal Cell & Gene Therapy Innovation Summit
Happy Mohamed
Monday, March 11, 2024
Lineage Cell Therapeutics Announces OpRegen P...
Benzinga Newsdesk
Friday, March 08, 2024
HC Wainwright & Co. Reiterates Buy on Lineage...
Benzinga Newsdesk
Thursday, March 07, 2024
Lineage Cell Therapeutics: Q4 Earnings Insights
Benzinga Insights
Lineage Cell Therapeutics Q4 2023 GAAP EPS $(...
Benzinga Newsdesk
Earnings Scheduled For March 7, 2024
Benzinga Insights
Wednesday, March 06, 2024
A Preview Of Lineage Cell Therapeutics's Earnings
Benzinga Insights
Wednesday, February 14, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Tuesday, February 13, 2024
HC Wainwright & Co. Reiterates Buy on Lineage...
Benzinga Newsdesk
Lineage Announces FDA Clearance Of IND Amendm...
Benzinga Newsdesk
Tuesday, February 06, 2024
Lineage Cell Therapeutics Announces $14M Mill...
Benzinga Newsdesk
Monday, February 05, 2024
Cantor Fitzgerald Reiterates Overweight on Li...
Benzinga Newsdesk
Thursday, February 01, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Tuesday, January 16, 2024
Lineage Cell Therapeutics, Inc. Announces RG6...
Benzinga Newsdesk
Wednesday, January 03, 2024
Lineage Cell Therapeutics, Longeveron And 2 Other Stocks Under $2 Insiders Are Buying
Avi Kapoor
Friday, December 29, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Monday, December 18, 2023
Lineage Cell Therapeutics, Inc. Submits Inves...
Benzinga Newsdesk
Thursday, November 09, 2023
Lineage Cell Therapeutics: Q3 Earnings Insights
Benzinga Insights
Lineage Cell Therapeutics Q3 EPS $(0.04), Inl...
Benzinga Newsdesk
Earnings Scheduled For November 9, 2023
Benzinga Insights
Wednesday, November 08, 2023
Earnings Preview: Lineage Cell Therapeutics
Benzinga Insights
Tuesday, October 24, 2023
RG6501 Phase 1/2a Results To Be Featured At E...
Benzinga Newsdesk
Wednesday, October 11, 2023
Lineage Announces Issuance Of U.S. Patent Cov...
Benzinga Newsdesk
Thursday, October 05, 2023
Lineage Cell Therapeutics' RG6501 (OpRegen) P...
Benzinga Newsdesk
Wednesday, September 13, 2023
Lineage Cell Therapeutics Announces RG6501 Ph...
Benzinga Newsdesk
Wednesday, September 06, 2023
EXCLUSIVE: Cell Therapy Player Lineage Cell Therapeutics Starts Development Activities Under Licensing Pact With Eterna Therapeutics
Vandana Singh
EXCLUSIVE: Lineage Cell Therapeutics Tells Be...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
